Mario Maimone Baronello
Overview
Explore the profile of Mario Maimone Baronello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giustozzi M, Acciarresi M, Agnelli G, Caso V, Bandini F, Tsivgoulis G, et al.
Stroke
. 2020 Jul;
51(8):2347-2354.
PMID: 32646335
Background And Purpose: The optimal timing for starting oral anticoagulant after an ischemic stroke related to atrial fibrillation remains a challenge, mainly in patients treated with systemic thrombolysis or mechanical...
2.
Altavilla R, Caso V, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, et al.
Stroke
. 2019 Jun;
50(8):2093-2100.
PMID: 31221054
Background and Purpose- Bridging therapy with low-molecular-weight heparin reportedly leads to a worse outcome for acute cardioembolic stroke patients because of a higher incidence of intracerebral bleeding. However, this practice...
3.
Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie K, et al.
J Am Heart Assoc
. 2018 Dec;
7(22):e010133.
PMID: 30571487
Background In patients with acute ischemic stroke and atrial fibrillation, early anticoagulation prevents ischemic recurrence but with the risk of hemorrhagic transformation ( HT ). The aims of this study...
4.
Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C, et al.
J Am Heart Assoc
. 2017 Dec;
6(12).
PMID: 29220330
Background: The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective observational multicenter study evaluated the rates...
5.
Acciarresi M, Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, et al.
J Stroke Cerebrovasc Dis
. 2017 Feb;
26(6):1363-1368.
PMID: 28236595
Background And Purpose: The aim of this study was to investigate for a possible association between both prestroke CHADS-VASc score and the severity of stroke at presentation, as well as...
6.
Paciaroni M, Agnelli G, Caso V, Tsivgoulis G, Furie K, Tadi P, et al.
Stroke
. 2017 Feb;
48(3):726-732.
PMID: 28183856
Background And Purposes: This study was designed to derive and validate a score to predict early ischemic events and major bleedings after an acute ischemic stroke in patients with atrial...
7.
Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, et al.
J Neurol
. 2015 Nov;
263(2):231-237.
PMID: 26566907
Anticoagulant therapy is recommended for the secondary prevention of stroke in patients with atrial fibrillation (AF). T he identification of patients at high risk for early recurrence, which are potential...
8.
Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, et al.
Stroke
. 2015 Jul;
46(8):2175-82.
PMID: 26130094
Background And Purpose: The best time for administering anticoagulation therapy in acute cardioembolic stroke remains unclear. This prospective cohort study of patients with acute stroke and atrial fibrillation, evaluated (1)...